Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:48 PM
Ignite Modification Date:
2025-12-24 @ 9:48 PM
NCT ID:
NCT03508232
Eligibility Criteria:
Inclusion Criteria:
1. 18+ year old
2. Diagnosis of acute ST-elevation myocardial infarction (STEMI)
3. Primary STEMI
4. Symptom onset of less than 12 hours
5. Admitted to the Royal Alexandra Hospital in Edmonton, Alberta
Exclusion Criteria:
1. Low risk inferior STEMI (total ST elevation plus depression \<4mm)
2. Cardiogenic shock
3. Use of thrombolytics
4. Prior history of myocardial infarction or heart failure
5. Known hypersensitivity to tetracyclines
6. Any concurrent medical condition expected to reduce life expectancy to \<1 year
7. Symptom onset to treatment (loading dose) time longer than 24 hours
8. Poor renal function (eGFR\<30 mL/min/1.73m2) or other contraindications to MRI (claustrophobia, pregnancy, PPM/ICD, sub-arachnoid clips, retained ocular foreign body)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03508232
Study Brief:
Protocol Section:
NCT03508232